After the success of its first super-speciality psychiatric neurocare centre in New Delhi, Rangsons Healthcare, a venture of the Mysore-based NR Group, launches its 2nd mindfulTMS Neurocare™ centre in India in ‘Bangalore’. 

The centre has been specially-designed to provide a holistic approach to treating mental illnesses with the US FDA-approved Transcranial Magnetic Stimulation (TMS) at its core.

mindfulTMS Neurocare, a global brand with a presence in the US, Europe and Asia, brings clinical expertise of neuropsychiatrists from the US, along with cutting-edge Transcranial Magnetic Stimulation (TMS) treatment and individually customized treatment protocols that have yielded successful results for treating mental illnesses over time.

Pavan Ranga, MD, Rangsons and Managing Partner, NR Group, along with Dr Vijay Mehtry, Consultant Psychiatrist, mindfulTMS Neurocare, Bangalore and Dr. Ajit Bhide, President of Indian Psychiatric Society(IPS) were present at the event. A Live demo to experience the working of TMS was organized by the clinic where the effectiveness of the treatment was spoken about in depth.

NR Group has invested around Rs 20-25 crore in this venture to address the mental health disorders such as depression and Obsessive Compulsive Disorder (OCD) particularly.